Potential T cell epitopes of mymA operon proteins capable of binding to MHC Class I and Class II alleles were identified.
Of mymA operon proteins Rv3083 was found to be the best vaccine candidate.
Molecular docking was performed with most promiscuous and antigenic epitopes of Rv3083 with MHC Class I and II molecules.
The software binding prediction was validated by the obtained molecular docking score of peptide-HLA complex.